Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid Cancer, Papillary × tipifarnib × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 3 Wilms Tumor 2 Sarcoma, Ewing 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Xanthogranuloma, Juvenile 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Pheochromocytoma 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma 1 Histiocytic Sarcoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Central Nervous System Neoplasms 1

Interventions

Vemurafenib 4 selpercatinib 3 Magnetic Resonance Spectroscopy 3 trametinib 2 entrectinib 2 dabrafenib 2 cobimetinib 2 X-Rays 2 Specimen Handling 2 tremelimumab 1 tovorafenib 1 spartalizumab 1 pralsetinib 1 pembrolizumab 1 lenvatinib 1 gallium Ga 68 dotatate 1 durvalumab 1 copanlisib 1 cabozantinib 1 Whole Body Imaging 1 Thyrotropin Alfa 1 Surveys and Questionnaires 1 Sunitinib 1 Robotic Surgical Procedures 1 Radiofrequency Ablation 1 Postoperative Period 1 Pharmacogenomic Testing 1 Phantoms, Imaging 1 Mitoxantrone 1 Iodine-131 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡